Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation
View Patent ↗One aspect of the current invention is a method of preventing and/or treating arthritis and/or preventing or treating lameness in a subject. Additionally, subject quality of life and welfare, and body condition scores are improved by utilizing methodology that administers the nucleic acid expression construct encoding a GHRH or functional biological equivalent to a subject through a parenteral route of administration. Following a single dose of nucleic acid expression vector, subjects are healthier and effects are demonstrated long term without additional administration(s) of the expression construct.
1. A method of alleviating symptoms of arthritis in a subject having arthritis comprising:
(i) delivering directly into a muscle tissue of the subject an effective amount of a nucleic acid expression construct in an amount in a range of about 0.1-5 mg and poly-L-glutamate, the construct comprising pig pAV0225 (SEQ ID NO: 26) encoding a growth-hormone-releasing-hormone (“GHRH”) to alleviate a symptom of arthritis;
(ii) electroporating the muscle tissue wherein the step of electroporating comprises:
a. penetrating the muscle tissue in the subject with a plurality of needle electrodes, wherein the plurality of needle electrodes are arranged in a spaced relationship and the muscle tissue of the subject comprise muscle cells; and
b. applying an electrical pulse to the plurality of needle electrodes, wherein the electrical pulse allow the nucleic acid expression construct to traverse a muscle cell membrane;
wherein the delivering step further comprises delivering between the plurality of needle electrodes;
wherein the subject comprises a horse; and
wherein the symptoms of arthritis comprise lameness.
2. A method of alleviating symptoms of arthritis in a subject having arthritis comprising:
(i) delivering directly into a muscle tissue of the subject an effective amount of a nucleic acid expression construct in an amount in a range of about 0.1-5 mg, the construct comprising a nucleotide sequence that encodes a growth-hormone-releasing-hormone (“GHRH”) consisting of an amino acid sequence of SEQ ID NO.: 2 to alleviate a symptom of arthritis;
(ii) electroporating the muscle tissue wherein the step of etectroporating comprises:
a. penetrating the muscle tissue in the subject with a plurality of needle electrodes, wherein the plurality of needle electrodes are arranged in a spaced relationship and the muscle tissue of the subject comprise muscle cells; and
b. applying an electrical pulse to the plurality of needle electrodes, wherein the electrical pulse allow the nucleic acid expression construct to traverse a muscle cell membrane;
wherein the delivering step further comprises delivering between the plurality of needle electrodes;
and wherein the symptom of arthritis comprises lameness.
3. The method of claim 2 , wherein the delivering step comprises delivering directly into a muscle tissue of the subject an effective amount of the nucleic acid expression construct and poly-L-glutamate.